These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36982296)

  • 1. The Role of Olfactomedin 2 in the Adipose Tissue-Liver Axis and Its Implication in Obesity-Associated Nonalcoholic Fatty Liver Disease.
    Barrientos-Riosalido A; Bertran L; Vilaró-Blay M; Aguilar C; Martínez S; Paris M; Sabench F; Riesco D; Binetti J; Castillo DD; Richart C; Auguet T
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Secreted Frizzled-Related Protein 5 mRNA Expression in the Adipose Tissue of Women with Nonalcoholic Fatty Liver Disease Associated with Obesity.
    Bertran L; Portillo-Carrasquer M; Barrientos-Riosalido A; Aguilar C; Riesco D; Martínez S; Culebradas A; Vives M; Sabench F; Castillo DD; Richart C; Auguet T
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Insights of OLFM2 and OLFM4 in Gut-Liver Axis and Their Potential Involvement in Nonalcoholic Fatty Liver Disease.
    Bertran L; Jorba-Martin R; Barrientos-Riosalido A; Portillo-Carrasquer M; Aguilar C; Riesco D; Martínez S; Vives M; Sabench F; Castillo DD; Richart C; Auguet T
    Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease.
    du Plessis J; van Pelt J; Korf H; Mathieu C; van der Schueren B; Lannoo M; Oyen T; Topal B; Fetter G; Nayler S; van der Merwe T; Windmolders P; Van Gaal L; Verrijken A; Hubens G; Gericke M; Cassiman D; Francque S; Nevens F; van der Merwe S
    Gastroenterology; 2015 Sep; 149(3):635-48.e14. PubMed ID: 26028579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.
    Suppli MP; Rigbolt KTG; Veidal SS; Heebøll S; Eriksen PL; Demant M; Bagger JI; Nielsen JC; Oró D; Thrane SW; Lund A; Strandberg C; Kønig MJ; Vilsbøll T; Vrang N; Thomsen KL; Grønbæk H; Jelsing J; Hansen HH; Knop FK
    Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G462-G472. PubMed ID: 30653341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased Hepatic
    Barrientos-Riosalido A; Real M; Bertran L; Aguilar C; Martínez S; Parada D; Vives M; Sabench F; Riesco D; Castillo DD; Richart C; Auguet T
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deregulation of Secreted Frizzled-Related Protein 5 in Nonalcoholic Fatty Liver Disease Associated with Obesity.
    Bertran L; Portillo-Carrasquer M; Aguilar C; Porras JA; Riesco D; Martínez S; Vives M; Sabench F; Gonzalez E; Del Castillo D; Richart C; Auguet T
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34198988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial respiration is decreased in visceral but not subcutaneous adipose tissue in obese individuals with fatty liver disease.
    Pafili K; Kahl S; Mastrototaro L; Strassburger K; Pesta D; Herder C; Pützer J; Dewidar B; Hendlinger M; Granata C; Saatmann N; Yavas A; Gancheva S; Heilmann G; Esposito I; Schlensak M; Roden M
    J Hepatol; 2022 Dec; 77(6):1504-1514. PubMed ID: 35988689
    [TBL] [Abstract][Full Text] [Related]  

  • 9.  Correlation of adipose tissue with liver histology in Asian Indian patients with nonalcoholic fatty liver disease (NAFLD).
    Choudhary NS; Duseja A; Kalra N; Das A; Dhiman RK; Chawla YK
    Ann Hepatol; 2012; 11(4):478-86. PubMed ID: 22700629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between IL-8 Circulating Levels and TLR2 Hepatic Expression in Women with Morbid Obesity and Nonalcoholic Steatohepatitis.
    Auguet T; Bertran L; Binetti J; Aguilar C; Martínez S; Sabench F; Lopez-Dupla JM; Porras JA; Riesco D; Del Castillo D; Richart C
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32545403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic lipidomic remodeling in severe obesity manifests with steatosis and does not evolve with non-alcoholic steatohepatitis.
    Ooi GJ; Meikle PJ; Huynh K; Earnest A; Roberts SK; Kemp W; Parker BL; Brown W; Burton P; Watt MJ
    J Hepatol; 2021 Sep; 75(3):524-535. PubMed ID: 33887358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinol binding protein-4 circulating levels were higher in nonalcoholic fatty liver disease vs. histologically normal liver from morbidly obese women.
    Terra X; Auguet T; Broch M; Sabench F; Hernández M; Pastor RM; Quesada IM; Luna A; Aguilar C; del Castillo D; Richart C
    Obesity (Silver Spring); 2013 Jan; 21(1):170-7. PubMed ID: 23505183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Adipose Tissue Fibrogenesis, Not Impaired Expandability, Is Associated With Nonalcoholic Fatty Liver Disease.
    Beals JW; Smith GI; Shankaran M; Fuchs A; Schweitzer GG; Yoshino J; Field T; Matthews M; Nyangau E; Morozov D; Mittendorfer B; Hellerstein MK; Klein S
    Hepatology; 2021 Sep; 74(3):1287-1299. PubMed ID: 33743554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations.
    Milić S; Lulić D; Štimac D
    World J Gastroenterol; 2014 Jul; 20(28):9330-7. PubMed ID: 25071327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Potential Protective Role of RUNX1 in Nonalcoholic Fatty Liver Disease.
    Bertran L; Pastor A; Portillo-Carrasquer M; Binetti J; Aguilar C; Martínez S; Vives M; Sabench F; Porras JA; Riesco D; Del Castillo D; Richart C; Auguet T
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34063472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic steatosis is associated with abnormal hepatic enzymes, visceral adiposity, altered myocardial glucose uptake measured by
    Hu L; Shao X; Qiu C; Shao X; Wang X; Niu R; Wang Y
    BMC Endocr Disord; 2020 May; 20(1):75. PubMed ID: 32460891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between subcutaneous adipocyte hypertrophy and nonalcoholic fatty liver disease.
    Holmer M; Hagström H; Chen P; Danielsson O; Aouadi M; Rydén M; Stål P
    Sci Rep; 2022 Nov; 12(1):20519. PubMed ID: 36443373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating Levels of Pro-Neurotensin and Its Relationship with Nonalcoholic Steatohepatitis and Hepatic Lipid Metabolism.
    Villar B; Bertran L; Aguilar C; Binetti J; Martínez S; Sabench F; Real M; Riesco D; París M; Del Castillo D; Richart C; Auguet T
    Metabolites; 2021 Jun; 11(6):. PubMed ID: 34200577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease.
    Rosso C; Kazankov K; Younes R; Esmaili S; Marietti M; Sacco M; Carli F; Gaggini M; Salomone F; Møller HJ; Abate ML; Vilstrup H; Gastaldelli A; George J; Grønbæk H; Bugianesi E
    J Hepatol; 2019 Nov; 71(5):1012-1021. PubMed ID: 31301321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered fatty acid metabolism-related gene expression in liver from morbidly obese women with non-alcoholic fatty liver disease.
    Auguet T; Berlanga A; Guiu-Jurado E; Martinez S; Porras JA; Aragonès G; Sabench F; Hernandez M; Aguilar C; Sirvent JJ; Del Castillo D; Richart C
    Int J Mol Sci; 2014 Dec; 15(12):22173-87. PubMed ID: 25474087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.